In this throwback episode, host Shikha Jain, MD, speaks with Elisabeth Potter, MD, about physicians pushing back against insurance companies, bringing physicians back into positions of autonomy and more.

· Welcome to another exciting episode of Oncology Overdrive 1:34

· About Potter 1:41

· The interview 2:04

· How did you decide to become a plastic surgeon? What was your path? 2:26

· How many years do you have to train for plastic surgery? 3:36

· What kind of physician is your father? […] Did you ever think you wanted to practice in the same field as him? 4:10

· Can you tell us about what happened that led you to post your recent viral video? 6:11

· Have you noticed an increase in insurance obstacles lately, or has it always been this way? 8:45

· When you talk to insurance companies, do you feel like you speak with someone who is qualified to understand these claims? 10:06

· Other than hiring people to deal with insurance claims, how can we work towards actually driving change in this space? 12:11

· Jain and Potter on the value of physicians knowing their worth and the cost of their care/procedures. 16:03

· Jain and Potter on the importance of physician autonomy. 23:21

· Potter and Jain on the changing national dialogue. 28:48

· When it comes to direct care models, how would patients be able to get second opinions? 33:53

· Are you optimistic that we will be able to realistically drive change? 35:37

· What do you suggest physicians, patients and advocates do to raise their voices and be heard? 35:56

· If someone could only listen to the last minute of this episode, what would you want listeners to take away? 40:14

· How to contact Potter 40:41

· Thanks for listening 41:38

Elisabeth Potter, MD, is a board-certified plastic surgeon offering a variety of plastic surgery, ranging from breast reconstruction to breast and body cosmetic procedures. We'd love to hear from you! Send your comments/questions to Dr. Jain at [email protected]. Follow Healio on X and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/. Follow Dr. Jain on X: @ShikhaJainMD. Potter can be reached on Instagram @drelisabethpotter, TikTok @drelisabethpotter and YouTube @DrElisabethPotterMD.

Disclosures: Jain and Potter report no relevant financial disclosures.

In this episode, host Shikha Jain, MD, speaks with Jennifer Karlin, MD, and Rachna Vanjani, MD, about being a resource to support health care providers, navigating the various policies surrounding sexual and reproductive health and more.

· Welcome to another exciting episode of Oncology Overdrive 1:02

· About Vanjani 1:18

· About Karlin 2:10

· The interview 3:13

· Rachna, can you tell us about what led you to becoming an OB-GYN and an advocate for reproductive justice? 3:25

· Jennifer, tell us about your journey and how you ended up becoming the principal investigator for the Reproductive Health Hotline. 8:53

· Can you tell us what the Reproductive Health Hotline is, why it was created and what is its mission? 16:22

· How are you managing the growing politicization of reproductive health in the US, and how are you protecting the people who call into this hotline? 24:04

· Discussion on the hotline providing national support and information. 30:17

· Jain, Vanjani and Karlin on the rising importance of resources like hotlines in health care. 34:14

· Do you feel like this is a book for physicians, patients, caregivers or everyone? 11:47

· If someone could only listen to the last couple of minutes of this episode, what would you want listeners to take away? 36:48

· How to contact Karlin and Vanjani 38:05

· Thanks for listening

Rachna Vanjani, MD, is a board certified OBGYN and reproductive justice advocate whose work focuses on equity, health care of incarcerated people, all trimester abortion care & access, and holistic medicine. Jennifer Karlin, MD, is an associate professor in the department of family and community medicine at the University of California, San Francisco. We'd love to hear from you! Send your comments/questions to Dr. Jain at [email protected]. Follow Healio on X and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/. Follow Dr. Jain on X: @ShikhaJainMD. Karlin and Vanjani can be reached via email at [email protected], or at www.reprohh.ucsf.edu. Call the Reproductive Health Hotline at 1-844-ReproHH (1-844-737-7644) and follow them on LinkedIn. Disclosures: Jain, Karlin and Vanjani report no relevant financial disclosures.

In this episode, host Shikha Jain, MD, speaks with Amy Comander, MD, about incorporating lifestyle medicine into cancer care, exciting advancements highlighted at the 2025 San Antonio Breast Cancer Symposium and more. • Welcome to another exciting episode of Oncology Overdrive 1:02 • About Comander 1:16 • The interview 3:42 • How do you find time to do everything that you do? 4:06 • When you started on your path, did you see your journey taking you to breast cancer, lifestyle medicine and authorship? How did you get to where you are today? 4:34 • Jain and Comander on the shifting mindset toward holistic patient care. 6:36 • Jain and Comander on the importance of lifestyle interventions in cancer care. 7:50 • Jain and Comander discuss optimizing survivorship. 9:04 • Tell us more about your latest book, PAVING Your Path Through Breast Cancer and Beyond […] What are you most excited about sharing from this book? 9:50 • Do you feel like this is a book for physicians, patients, caregivers or everyone? 11:47 • Is there anything related to lifestyle medicine, or breast oncology in general, that you are looking forward to hearing about at this year's San Antonio Breast Cancer Symposium? 14:38 • What are your thoughts on ESMO's latest press release regarding mRNA COVID vaccines and improved response to immunotherapy? 17:29 • Jain and Comander on specific lifestyle interventions to improve quality and quantity of life, as well as "guilty pleasures". 20:23 • How do you train for all the marathons you run, and when do you find the time to train regularly? 21:43 • What are the things that you are looking forward to seeing in the breast cancer space over the next decade in cancer care? 25:24 • If someone could only listen to the last minute of this episode, what would you want listeners to take away? 27:37 • How to contact Comander 28:45 • Thanks for listening 29:42 Amy Comander, MD, DipABLM, FACLM, MSCP, is a breast oncologist and medical director of the Mass General Brigham Cancer Institute in Waltham, director of the lifestyle medicine program at the Mass General Brigham Cancer Institute, and an instructor in medicine at Harvard Medical School. You can get a copy of her new book, PAVING Your Path Through Breast Cancer, here.

We'd love to hear from you! Send your comments/questions to Dr. Jain at [email protected]. Follow Healio on X and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/. Follow Dr. Jain on X: @ShikhaJainMD. Comander can be reached on Instagram @dramycomander, LinkedIn, or via email [email protected]. References • Grippin AJ, et al. Nature. 2025;doi:10.1038/s41586-025-09655-y. • PAVING the Path to Wellness. https://www.massgeneral.org/cancer-center/patient-and-family-resources/supportive-care/paving. Published 2021. Accessed November 11, 2026

Disclosures: Jain and Comander report no relevant financial disclosures.

In this episode, host Shikha Jain, MD, speaks with Jason Williams, MD, and Nathan Goodyear, MD, about innovations in immunotherapy, the future of cancer care and more. • Welcome to another exciting episode of Oncology Overdrive 1:02 • About Williams 1:12 • About Goodyear 1:56 • The interview 3:08 • Nathan, can you explain the concept of your medical philosophy, Docēre rāphè, and how you integrate it into your practice? 3:29 • Jason, how did you get to where you are today, and how did you end up founding the Williams Cancer Institute? 5:28 • Nathan, as an OB-GYN and lifestyle physician, what was your path to this space and at Williams Cancer Institute? 14:22 • How do you both navigate being creative in the current climate of misinformation from a patient and physician standpoint? 20:17 • Jason, what are the benefits and challenges of practicing in other countries versus in the United States? 26:05 • Discussion on patient education through scientific evidence and innovation. 31:00 • If someone could only listen to the last minute of this episode, what would you want listeners to take away? 33:37 • How to contact Goodyear & Williams 35:42 • Thanks for listening 36:11

Jason Williams, MD, DABR, is a medical doctor, board-certified radiologist and image-guided cancer specialist. As a leader in immunotherapy, he performed the world's first ablation procedure combined with intra-tumoral immunotherapy injections. Dr. Williams serves as the Director of Interventional Oncology and Immunotherapy at the Williams Cancer Institute, which he founded to advance innovative cancer treatments.

Nathan Goodyear, MD, MD(H), is an integrative medicine physician, board-certified in obstetrics and gynecology, and a leader in wellness and cancer prevention. He specializes in functional and regenerative medicine, focusing on healing and teaching the body to restore itself. Dr. Goodyear works at the Williams Cancer Institute, pioneering innovative cancer care with a holistic approach.

We'd love to hear from you! Send your comments/questions to Dr. Jain at [email protected]. Follow Healio on X and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/. Follow Dr. Jain on X: @ShikhaJainMD. Goodyear and Williams can be reached at williamscancerinstitute.com. Disclosures: Jain, Goodyear and Williams report no relevant financial disclosures.

In this episode, host Shikha Jain, MD, speaks with Maureen McBeth, PT, MPT, CLT-LANA, about understanding individualized patient experiences with lymphedema, the value of exercise oncology and more. • Welcome to another exciting episode of Oncology Overdrive 0:14 • About McBeth 0:23 • The interview 0:52 • How did you end up in the lymphedema and cancer rehab space? 1:31 • Why is lymphedema such a big topic, especially in the breast cancer space? 3:20 • Jain and McBeth on the complexities of individual lymphedema cases, including studies on lymphatic imaging. 5:25 • Do you feel like there have been advancements in the lymphedema space that can improve our understanding of it? 9:43 • Have stigmas around lymphedema evolved over the years? 12:31 • McBeth on the educational materials available to physicians surrounding cancer-related lymphedema and prospective surveillance. 15:15 • Tell us about ImpediMed and its purpose. 17:06 • How do you incorporate these technologies into the current dialogue about more holistic care? 21:27 • Jain and McBeth on exercise oncology and its impact on overall survival. 24:22 • In ten years, what would you envision as the future of lymphedema and exercise oncology? 29:01 • If someone could only listen to the last few minutes of this episode, what would you want listeners to take away? 32:31 • How to contact McBeth 33:33 • Thanks for listening 34:20

Maureen McBeth, PT, MPT, CLT-LANA, is a licensed physical therapist and certified lymphedema therapist with over 25 years of experience in oncology rehabilitation, clinical education, and patient advocacy. She currently serves as senior medical affairs liaison at ImpediMed.

We'd love to hear from you! Send your comments/questions to Dr. Jain at [email protected]. Follow Healio on X and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/. Follow Dr. Jain on X: @ShikhaJainMD. McBeth can be reached via email [email protected]. Learn more about ImpediMed at https://www.impedimed.com/, or follow them on LinkedIn or Instagram @impedimedhealth.

References • Pasket ED, et al. J Clin Oncol. 2012;doi:10.1200/JCO.2012.41.8574 • Schmitz KH, et al. J Natl Cancer Inst Monogr. 2025;doi:10.1093/jncimonographs/lgaf007. • Stout NL, et al. Cancer. 2012;doi:10.1002/cncr.27476.

Disclosures: Jain and McBeth report no relevant financial disclosures.

In this episode, host Shikha Jain, MD, speaks with Shakira Grant, MBBS, about providing patients and physicians with the proper education on AI tools, focusing on marginalized communities and more. • Welcome to another exciting episode of Oncology Overdrive 0:14 • About Grant 0:26 • The interview 2:07 • How did you get to where you are today? 2:38 • Tell me about how you got into the AI space […] What aspects interest you specifically? 4:19 • Can you take me step-by-step through how CROSS works with different health care organizations? 8:05 • How does CROSS address concerns about AI? 10:33 • Do you think AI could widen our disparities if it's taking its prompts from biases in humans? 13:31 • How do we educate people about fixing the challenges presented by AI so that we can use this data more accurately? 16:38 • Where do you see this going? […] What would you view as success in the next ten years? 18:22 • How are you managing the current political climate with this type of work? 21:31 • What do you plan to do next in your own career? 27:42 • If someone could only listen to the last few minutes of this episode, what would you want listeners to take away? 29:25 • How to contact Grant 30:23 • Thanks for listening 31:28

Shakira J. Grant, MBBS, MSCR, is a physician, entrepreneur, and healthcare executive who works at the intersection of clinical medicine, health policy, and artificial intelligence. She is the founder of CROSS Global Research & Strategy, LLC (CROSS), a company dedicated to providing end-to-end solutions that ease the adoption of AI in healthcare.

We'd love to hear from you! Send your comments/questions to Dr. Jain at [email protected]. Follow Healio on X and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/. Follow Dr. Jain on X: @ShikhaJainMD. Grant can be reached on LinkedIn or via email [email protected].

Disclosures: Jain and Grant report no relevant financial disclosures.

In this episode, host Shikha Jain, MD, speaks with James Hamrick, MD, and Sanjeev Kumar about the value of biomarker testing and precision oncology, personal journeys with patient advocacy and more. • Welcome to another exciting episode of Oncology Overdrive 1:05 • About Kumar 1:20 • About Hamrick 1:52 • The interview 2:30 • Sanjeev, can you tell us about how you got involved in oncology and immunology? 2:59 • James, how did you get into this space and start working with Caris Life Sciences? 7:15 • Sanjeev, how did your mother's experience unfold, and how did you incorporate your personal knowledge help advocate and navigate throughout the situation? 12:00 • Hamrick and Kumar on the importance of patient advocacy. 17:44 • Jain, Hamrick and Kumar on the impact precision oncology can have on personalized cancer care. 23:57 • How do we make current innovations available to everyone? How can we help advocate for patients in rural areas? 28:33 • Hamrick on how precision oncology helps support decision-making for physicians and community oncologists. 35:13 • Jain, Hamrick and Kumar on the art and practice of medicine. 40:57 • If someone could only listen to the last minute of this episode, what would you want listeners to take away? 41:53 • How to contact Kumar 44:13 • How to contact Hamrick 44:34 • Thanks for listening 45:14 James Hamrick, MD, MPH, is the chairman of the Caris Precision Oncology Alliance™ (Caris POA) at Caris Life Sciences.

Sanjeev Kumar is chairman and CEO of the Gallbladder Cancer Foundation, and is a biotech manufacturing leader with a background in immunology from UC Berkeley.

We'd love to hear from you! Send your comments/questions to Dr. Jain at [email protected]. Follow Healio on X and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/. Follow Dr. Jain on X: @ShikhaJainMD. Kumar can be reached via email at [email protected], or at the Gallbladder Cancer Foundation website. Hamrick can be reached at the Caris Life Sciences website.

Disclosures: Jain and Kumar report no relevant financial disclosures. Hamrick reports being an employee of Caris Life Sciences and an advisor to Community Oncology Partners LLC.

In this special edition episode, recorded live at the ASCO Annual Meeting, hosts Shikha Jain, MD, and Edward Kim, MD, honor Healio's 2025 Disruptive Innovators for their positive disruption in the field of hematology/oncology, and for pushing the status quo to improve clinical practice. • Welcome to the fourth annual Healio Disruptive Innovator Awards in hematology/oncology. 1:00 • VK Gadi, MD PhD, presents the Health Equity Award. 3:56 • The Health Equity Award winner, Ana Velázquez Mañana, MD, makes a speech. 6:00 • Morgan Collier presents the Woman Disruptor of the Year Award. 7:38 • Betty S. Pace, MD, accepts the Woman Disruptor of the Year Award. 9:19 • The Social Media Influencer Award, presented by Eleonora Teplinsky, MD. 11:53 • Amani Jambhekar, MD, also known as @ajvictorymd on Instagram and TikTok, accepts the Social Media Influencer Award. 13:13 • Brenda M. Nevidjon, MSN, RN, FAAN, presents the Advanced Practice Trailblazer Award. 14:40 • Ashley Leak Bryant, PhD, RN, OCN, FAAN, delivers her acceptance speech for the Advanced Practice Trailblazer Award. 16:19 • Kamal Jethwani, MD, MPH, presents the Patient Voice Award. 18:44 • Founder Kimberly Richardson, MA, accepts the Patient Voice Award for the Black Cancer Collaborative. 20:44 • Healio's chief content officer, Joan-Marie Stiglich, ELS, presents the NextGen Disruptor Award to Nazli Dizman, MD. 22:22 • The Clinical Innovation Award goes to UNC Lineberger Comprehensive Cancer Center for their at-home symptom reporting, led by Ethan Basch, MD, MSc. 24:18 • Hope S. Rugo, MD, wins the Lifetime Disruptor Award. 26:48 • The Industry Breakthrough Award goes to Breyanzi (lisocabtagene maraleucel, or liso-cel) from Bristol Myers Squibb. 30:57 • On behalf of Bristol Myers Squibb, Amy Corrao, MSN, NP-C, accepts the Industry Breakthrough Award. 32:33 • Thanks to all of the winners, nominees and sponsors! 35:39 • Thanks for listening. 36:21

We'd love to hear from you! Send your comments/questions to Dr. Jain at [email protected]. Follow Healio on X and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/. Follow Dr. Jain on X: @ShikhaJainMD. Read the full coverage from Healio's Disruptive Innovators here.

In this episode, host Shikha Jain, MD, speaks with Mika Stambaugh about bridging the patient and doctor information gap, her personal journey with patient advocacy and more. • Welcome to another exciting episode of Oncology Overdrive 1:34 • About Stambaugh 1:43 • The interview 4:00 • How did you get into media and PR? […] What Was your journey to get to this point in your career? 4:31 • Have you seen the evolution of people in health care speaking with the media? 6:57 • How do you remain objective when discussing hot button political topics with experts? 10:05 • Who is the coolest or most interesting person you have interviewed? 11:08 • Can you tell us about your recent cancer diagnosis and how it impacted you? 13:25 • How did your facial Mohs surgery impact your career? 18:39 • What was it about this situation that made you decide to share your journey publicly? 24:11 • Do you recommend getting a second opinion to people? How did the decision to seek out a second opinion come about for you? 27:57 • Do you see yourself continuing to work in the patient advocacy space? 30:35 • If someone could only listen to the last minute of this episode, what would you want listeners to take away? 36:50 • How to contact Stambaugh 37:55 • Thanks for listening 39:05 Mika Stambaugh is an Emmy award winning journalist and dynamic entrepreneur.

We'd love to hear from you! Send your comments/questions to Dr. Jain at [email protected]. Follow Healio on X and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/. Follow Dr. Jain on X: @ShikhaJainMD. Stambaugh can be reached @MikaStambaugh on X and @mikastambaugh on Instagram, or via email [email protected].

Disclosures: Jain and Stambaugh report no relevant financial disclosures.

In this episode, host Shikha Jain, MD, speaks with Elisabeth Potter, MD, about physicians pushing back against insurance companies, bringing physicians back into positions of autonomy and more. • Welcome to another exciting episode of Oncology Overdrive 1:34 • About Potter 1:41 • The interview 2:04 • How did you decide to become a plastic surgeon? What was your path? 2:26 • How many years do you have to train for plastic surgery? 3:36 • What kind of physician is your father? […] Did you ever think you wanted to practice in the same field as him? 4:10 • Can you tell us about what happened that led you to post your recent viral video? 6:11 • Have you noticed an increase in insurance obstacles lately, or has it always been this way? 8:45 • When you talk to insurance companies, do you feel like you speak with someone who is qualified to understand these claims? 10:06 • Other than hiring people to deal with insurance claims, how can we work towards actually driving change in this space? 12:11 • Jain and Potter on the value of physicians knowing their worth and the cost of their care/procedures. 16:03 • Jain and Potter on the importance of physician autonomy. 23:21 • Potter and Jain on the changing national dialogue. 28:48 • When it comes to direct care models, how would patients be able to get second opinions? 33:53 • Are you optimistic that we will be able to realistically drive change? 35:37 • What do you suggest physicians, patients and advocates do to raise their voices and be heard? 35:56 • If someone could only listen to the last minute of this episode, what would you want listeners to take away? 40:14 • How to contact Potter 40:41 • Thanks for listening 41:38 Elisabeth Potter, MD, is a board-certified plastic surgeon offering a variety of plastic surgery, ranging from breast reconstruction to breast and body cosmetic procedures.

We'd love to hear from you! Send your comments/questions to Dr. Jain at [email protected]. Follow Healio on X and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/. Follow Dr. Jain on X: @ShikhaJainMD. Potter can be reached on Instagram @drelisabethpotter, TikTok @drelisabethpotter and YouTube @DrElisabethPotterMD.

Disclosures: Jain and Potter report no relevant financial disclosures.